AIHealthcare

AKASA is a private healthcare AI company focused on revenue-cycle operations for health systems. Its platform uses healthcare-optimized generative AI and custom large language models to analyze patient records and surface evidence-backed documentation and coding opportunities; it also addresses complex revenue-cycle workflows such as coding, prior authorization, claims, and denials. The company describes its market position as a generative-AI partner for health systems and cites Cleveland Clinic among its partners. Ensemble Health Partners is a separate, private, technology-enabled revenue-cycle managed-services provider rather than the same company as AKASA. Ensemble provides end-to-end revenue-cycle management—such as patient access, coding, claims, denial prevention, accounts-receivable follow-up, billing, payments, and patient financial experience—and combines operations, data-driven intelligence, and AI. Ensemble describes itself as a leading national end-to-end RCM managed-services partner; its June 2026 announcement stated that Thoreau agreed to make a strategic growth investment, with Berkshire Partners, Warburg Pincus, and Bon Secours Mercy Health continuing as investors. The announced transaction value was not disclosed by Ensemble; third-party reports estimated approximately $12B.